However, anti-VEGFA therapy is a direct reduction in the rate of tumour growth rather than an induction of tumour regression, and some drugs slow tumour growth without necessarily causing tumour shrinkage (Bagri et al., 2010). Here, VEGFA is linked to neoplasm.